Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Roose

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Translational Psychiatry|October 4, 2022
Correction to: Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 19, 2015
A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life DepressionMonique A Pimontel, David Rindskopf, Bret R Rutherford, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2011
Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contactBret R Rutherford, Joel R Sneed, Jane M Tandler, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Speed of processing and depression affect function in older adults with mild cognitive impairmentPatrick J Brown, Xinhua Liu, Joel R Sneed, et al.
Translational Psychiatry|September 16, 2021
Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 14, 2007
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionJoel R Sneed, Bret R Rutherford, David Rindskopf, et al.
Depression and Anxiety|October 6, 2015
INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALSBret R Rutherford, Veronika S Bailey, Franklin R Schneier, et al.
JAMA Psychiatry|October 17, 2014
Placebo response in antipsychotic clinical trials: a meta-analysisBret R Rutherford, Emily Pott, Jane M Tandler, et al.
The Journal of Clinical Psychiatry|August 16, 2013
Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropoutBret R Rutherford, Timothy M Cooper, Amanda Persaud, et al.
International Journal of Geriatric Psychiatry|March 1, 2013
The external validity of MRI-defined vascular depressionMonique A Pimontel, Michelle E Reinlieb, Lauren C Johnert, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Translational Psychiatry|October 4, 2022
Correction to: Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 19, 2015
A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life DepressionMonique A Pimontel, David Rindskopf, Bret R Rutherford, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2011
Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contactBret R Rutherford, Joel R Sneed, Jane M Tandler, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Speed of processing and depression affect function in older adults with mild cognitive impairmentPatrick J Brown, Xinhua Liu, Joel R Sneed, et al.
Translational Psychiatry|September 16, 2021
Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 14, 2007
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionJoel R Sneed, Bret R Rutherford, David Rindskopf, et al.
Depression and Anxiety|October 6, 2015
INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALSBret R Rutherford, Veronika S Bailey, Franklin R Schneier, et al.
JAMA Psychiatry|October 17, 2014
Placebo response in antipsychotic clinical trials: a meta-analysisBret R Rutherford, Emily Pott, Jane M Tandler, et al.
The Journal of Clinical Psychiatry|August 16, 2013
Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropoutBret R Rutherford, Timothy M Cooper, Amanda Persaud, et al.
International Journal of Geriatric Psychiatry|March 1, 2013
The external validity of MRI-defined vascular depressionMonique A Pimontel, Michelle E Reinlieb, Lauren C Johnert, et al.
Pageof 15